OmniBuyer users will be able to purchase supplies via the Internet from GHX’s comprehensive industry-standard catalog. More than 70 manufacturers and distributors are currently members of GHX, and together they represent more than 80 percent of the supplies and materials purchased by hospitals.

“This partnership with GHX will provide our OmniBuyer customers with access to the world’s leading health care manufacturers and distributors,” said Shelly Asher, president and CEO of Omnicell. “The alliance supports our vision of simplifying the purchasing needs of health care facilities.”

Omnicell provides a complete end-to-end solution for the supply chain management needs of the health care industry. Through Omnicell’s systems, users have convenient control over the dispensing and management of supplies and medications at the point of use. With OmniBuyer, health care facilities can realize the efficiencies associated with purchasing their supplies on line.

The companies expect to integrate their first joint customer, Chicago-based Rush-Presbyterian-St. Luke’s Medical Center, by early April, 2001.

“Using Omnicell to access GHX provides us with a complete solution to our procurement needs,” says John Cashmore, director of purchasing for Rush-Presbyterian. “Individual hospital departments will have the convenience of placing orders through OmniBuyer -- and GHX’s catalog will ensure those departments can make purchasing decisions and track orders based on the most complete and reliable information direct from the suppliers and distributors.”

GHX’s Internet-based technology was developed exclusively for the health care industry. The company’s end-to-end solution gives hospitals single source ordering capabilities for both medical and non-medical products. As suppliers update product pricing, availability and other information, hospitals will be able to instantly access the revised data.

“Partnering with Omnicell is a key factor in achieving our overall goal of providing convenient connectivity options for our customers,” says GHX President Mike Mahoney. “We look forward to providing the more than 1300 hospitals and health care facilities currently using Omnicell with access to the Exchange. Omnicell’s supply inventory and use management services provide the perfect complement to GHX’s on-line catalog and order tracking services.”

About Global Healthcare Exchange

Global Healthcare Exchange, LLC (GHX), provides business-to-business procurement solutions for the health care industry. Utilizing Internet-based technology, the company seamlessly integrates hospitals and suppliers, thereby improving efficiencies and adding value throughout the supply chain. GHX provides single-source ordering and tracking for both medical and non-medical products. The privately held company was founded in March 2000 and now comprises more than 70 supplier members and more than 160 hospital members. Equity members of GHX include Johnson & Johnson, GE Medical Systems, Baxter International Inc., Abbott Laboratories, Medtronic Inc., Becton, Dickinson and Co., Boston Scientific Corporation, C.R. Bard Inc., Guidant Corporation and Tyco International, Ltd. For more information, visit www.ghx.com.

About Omnicell

Established in 1992, Omnicell enables health care organizations to improve the efficiency of their supply chains. Omnicell provides automated supply and pharmacy product dispensing at the point of use, Internet-based e-procurement solutions powered by Commerce One’s business-to-business e-commerce technology, integration services, data analysis, and a content Web site for health care professionals. For more information, visit www.omnicell.com.

The statements contained in this release may be deemed to contain “forward-looking statements.” Such statements are indicated by words or phrases such as “anticipate,” “estimate,” “projects,” “believes,” “intends,” “expects” and similar words and phrases. Actual results may differ materially from those expressed or implied in any forward-looking statement as a result of certain risks and uncertainties, including, without limitation, development of new capabilities for the launch of the Omnicell Commerce Network; adoption of the Internet for business transactions by health care organizations; volume of transactions for medical products, services and equipment over the Internet; development of relationships with suppliers of health care products and services, automation systems and GPOs; and other risks and uncertainties detailed in the Company’s Securities and Exchange Commission filings. Prospective investors are cautioned not to place undue reliance on such forward-looking statements.